Hudson Capital Management LLC Amgen Inc Transaction History

Hudson Capital Management LLC

$302 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $1.86 Million - $2.17 Million	-8,741 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $3,503 - $3,887	15 Added 0.17%	8,741 $2.13 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $28,848 - $33,618	130 Added 1.51%	8,726 $2.17 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $40,030 - $47,668	-185 Reduced 2.11%	8,596 $1.98 Million
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $61,478 - $68,368	-262 Reduced 2.9%	8,781 $2.23 Million
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $76,354 - $93,697	-386 Reduced 4.09%	9,043 $2.13 Million
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $96,404 - $127,859	-529 Reduced 5.31%	9,429 $1.91 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $49,573 - $63,718	-262 Reduced 2.56%	9,958 $2.4 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $90,537 - $108,482	520 Added 5.36%	10,220 $1.98 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $168,700 - $197,754	1,012 Added 11.65%	9,700 $1.79 Billion
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $89,711 - $101,124	496 Added 6.05%	8,688 $0
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $10,525 - $12,286	59 Added 0.73%	8,192 $1.6 Million
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $76,710 - $86,480	414 Added 5.36%	8,133 $1.69 Million
Q2 2018 Jul 11, 2018	BUY	$166.05 - $186.51 $120,054 - $134,846	723 Added 10.33%	7,719 $1.43 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $92,847 - $108,504	548 Added 8.5%	6,996 $1.19 Million
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $1.09 Million - $1.22 Million	6,448	6,448 $1.12 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Capital Management LLC with notifications on news.

Account